Kite Pharma, Inc. 소개
Kite Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous CAR T cell therapy - a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.
Source: Wikipedia
산업Biotechnology
본사Santa Monica, CA
설립2009
법적 형태C Corporation
상태운영 중
특허특허 863건
GPC3 BINDING MOLECULESUS20260242507A1 · 2026
Methods of administering chimeric antigen receptor immunotherapyUS12709639B2 · 2026
주요 수치
법적 정보
| 법인명 | Kite Pharma, Inc. |
|---|---|
| 법적 형태 | C Corporation |
| SEC CIK | 1510580SEC EDGAR에서 보기 ↗ |
| 등기 주소 | Santa Monica, CA |
| 상태 | 운영 중 |
출처: SEC EDGAR · 2026년 11월 14일 업데이트